Parasite killer Ivermectin stops cancer drug resistance 24 November 2019
A widely available insecticide, Ivermectin, has been shown to make drug-resistant tumours and leukaemia immediately responsive to the drugs; this is not the first time anti-cancer activity has been shown, with previous research on breast, ovarian, lymphoma and TNBC, plus studies showing improved response to Adriamycin and Taxol.
You’re funny. I’ve stocked up on HCQ, Ivermectin and Fenbendazole. Patiently awaiting their next wet market release!